Bioorganic and Medicinal Chemistry Letters p. 803 - 806 (1996)
Update date:2022-09-26
Topics:
Chapman, Kevin T.
Durette, Philippe L.
Caldwell, Charles G.
Sperow, Kelly M.
Niedzwiecki, Lisa M.
Harrison, Richard K.
Saphos, Cheryl
Christen, Amy J.
Olszewski, Julie M.
Moore, Vernon L.
MacCoss, Malcolm
Hagmann, William K.
Further development of N-carboxyalkyl dipeptide inhibitors of stromelysin-1 (MMP-3) led to the discovery of C-carboxyalkyl dipeptide analogs with improved oral bioavailability. An in vivo assay of human MMP-3 mediated degradation of a macromolecular substrate in an extravascular space is described and inhibition studies are reported.
View MoreShanghai Dano Pharmaceutical Co.,Ld.(expird)
Contact:+86-592-6266840
Address:Building 1 Room 512, 720 Cailun Rd, Zhangjiang High-Tech Park, Shanghai 201203, China
puyang hongda shengdao new material co.,ltd.
Contact:+86-393- 4896278
Address:No.29 East Zhongyuan Road
Ji'nan Orgachem Pharmaceutical Co.,Ltd
Contact:+86-531-82687810
Address:Jinan
Contact:732.938.2777
Address:5012 Industrial Road Farmingdale, NJ 07727
HangZhou HuaYe Chemical Technology Co.,Ltd
Contact:+86-13505815007
Address:hangzhou
Doi:10.1016/0008-6215(67)85008-0
(1967)Doi:10.1021/om990385y
(2000)Doi:10.1002/ejoc.201402180
(2014)Doi:10.1039/C19660000355
(1966)Doi:10.1016/0040-4039(95)00387-R
(1995)Doi:10.1021/jo00099a037
(1994)
